Oracle's Mounting Challenges: A Test of Investor Faith
03.03.2026 - 00:54:39 | boerse-global.deOracle finds itself navigating a critical juncture. The initial promise of a major AI growth narrative is now clouded by legal entanglements and financial strain. A recently filed class action lawsuit alleges misleading statements by management, while soaring expenditures are pressuring cash flows. With quarterly results imminent, skepticism is mounting over whether the company's massive backlog represents solid value or a perilous gamble.
Financial Strain Takes Center Stage
The financial realities underpinning Oracle's AI strategy are causing significant concern on Wall Street. The company recently reported a negative free cash flow exceeding $10 billion. Furthermore, a disclosure within its quarterly report—described by some analysts as a "bomb"—revealed lease commitments totaling $248 billion, almost exclusively for data centers and cloud capacity.
Unlike many competitors, Oracle is currently funding this aggressive expansion not from operational cash flow but increasingly through debt. This financial dynamic helps explain the stock's severe decline: shares have lost approximately 52% of their value since their all-time high and are trading well below key moving averages.
The Concentrated Risk of OpenAI
On paper, Oracle's position appears robust. Its remaining performance obligations (RPO) have ballooned to a colossal $523.3 billion. However, experts are warning of a substantial concentration risk. Roughly $300 billion of this backlog is attributed to a single client: OpenAI.
S&P Global Ratings has noted that OpenAI could account for more than one-third of Oracle's total revenue by 2028. This dependence on the financial health of a single entity, which itself has enormous capital requirements, is viewed as risky. Investor confidence was further shaken when financier Blue Owl Capital recently withdrew from a $10 billion project for an OpenAI data center.
Should investors sell immediately? Or is it worth buying Oracle?
Legal Action Compounds Uncertainty
Market uncertainty is being fueled by a new lawsuit from the firm Kessler Topaz Meltzer & Check. The legal allegations are serious: Oracle is accused of deceiving investors regarding the true capacity of its data centers and the associated costs. Statements made between June and December 2025 are under scrutiny.
The lawsuit was triggered by revelations following the second-quarter results. While revenue growth fell short of expectations, capital expenditure (CapEx) exploded. Management revised its expenditure forecast for fiscal year 2026 upward to $50 billion—a sharp increase of $15 billion from an estimate provided just in September. Analysts are particularly critical that Oracle did not raise its 2026 revenue forecast alongside this massive spending increase.
All Eyes on the March 9th Report
The crucial test arrives this coming Monday when Oracle releases its third-quarter financials. Market experts anticipate earnings of $1.71 per share on revenue of $16.9 billion. Management is under intense pressure to demonstrate that its record-level investments and lease commitments can indeed be converted into profitable revenue streams. Should the numbers again reveal a widening gap between cost explosion and earnings growth, the stock's downward trajectory will likely accelerate.
Ad
Oracle Stock: New Analysis - 3 March
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Oracles Aktien ein!
Für. Immer. Kostenlos.
